Kanqiu Jiang

552 total citations
15 papers, 406 citations indexed

About

Kanqiu Jiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kanqiu Jiang has authored 15 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Kanqiu Jiang's work include Cancer Immunotherapy and Biomarkers (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (2 papers). Kanqiu Jiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (2 papers). Kanqiu Jiang collaborates with scholars based in China. Kanqiu Jiang's co-authors include Mingjing Shen, Weihua Xu, Yongbing Chen, Fuquan Zhang, Zhonghua Xu, Qifeng Ding, Jingjing Lu, Yi Yang, Zhe Lei and Shanzhou Duan and has published in prestigious journals such as Cell Death and Disease, International Journal of Nanomedicine and Lung Cancer.

In The Last Decade

Kanqiu Jiang

15 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanqiu Jiang China 11 242 128 115 68 51 15 406
Lanya Li China 7 285 1.2× 132 1.0× 79 0.7× 38 0.6× 45 0.9× 12 433
Isabelle Moranvillier France 12 337 1.4× 117 0.9× 136 1.2× 33 0.5× 54 1.1× 18 495
Vahideh Zarrin Iran 7 238 1.0× 89 0.7× 153 1.3× 46 0.7× 40 0.8× 9 405
Peipei Nie China 8 277 1.1× 71 0.6× 163 1.4× 23 0.3× 35 0.7× 8 400
Sara El‐Sahli Canada 8 232 1.0× 125 1.0× 121 1.1× 56 0.8× 41 0.8× 14 368
Malaney R. O’Connell United States 7 187 0.8× 220 1.7× 123 1.1× 40 0.6× 32 0.6× 10 407
Shengyong Yang China 13 187 0.8× 103 0.8× 29 0.3× 36 0.5× 48 0.9× 18 356
Karolina Weiner‐Gorzel Ireland 5 416 1.7× 180 1.4× 250 2.2× 77 1.1× 50 1.0× 7 587
Poulami Khan India 11 334 1.4× 210 1.6× 143 1.2× 73 1.1× 40 0.8× 15 542
Zike Yang China 6 219 0.9× 130 1.0× 114 1.0× 89 1.3× 46 0.9× 12 419

Countries citing papers authored by Kanqiu Jiang

Since Specialization
Citations

This map shows the geographic impact of Kanqiu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanqiu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanqiu Jiang more than expected).

Fields of papers citing papers by Kanqiu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanqiu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanqiu Jiang. The network helps show where Kanqiu Jiang may publish in the future.

Co-authorship network of co-authors of Kanqiu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Kanqiu Jiang. A scholar is included among the top collaborators of Kanqiu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanqiu Jiang. Kanqiu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xu, Weihua, et al.. (2025). NADH:ubiquinone oxidoreductase core subunit S8 expression and functional significance in non-small cell lung cancer. Cell Death and Disease. 16(1). 321–321. 1 indexed citations
2.
Sun, Dantong, Yongbing Chen, Qiang Yuan, et al.. (2024). CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis. Journal of Experimental & Clinical Cancer Research. 43(1). 202–202. 11 indexed citations
3.
Jiang, Kanqiu, Shasha Liu, Yongbing Chen, et al.. (2023). Characterization of TCF‐1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients. Thoracic Cancer. 14(27). 2745–2753. 3 indexed citations
4.
Jiang, Kanqiu, et al.. (2022). Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth. Cell Death and Disease. 13(7). 602–602. 27 indexed citations
5.
Ma, Kaili, Lina Sun, Mingjing Shen, et al.. (2022). Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8+ T cell exhaustion. iScience. 25(5). 104347–104347. 15 indexed citations
6.
Zhang, Jin‐Zhi, Jia Liu, Yixin Xu, et al.. (2022). Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC. International Journal of Biological Sciences. 18(16). 6163–6175. 11 indexed citations
7.
Shen, Mingjing, Kanqiu Jiang, Zhonghua Xu, et al.. (2021). Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung Cancer. 160. 84–91. 7 indexed citations
8.
Shen, Mingjing, Zhonghua Xu, Weihua Xu, et al.. (2019). Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 149–149. 157 indexed citations
9.
Jiang, Kanqiu, Ting Zhao, Mingjing Shen, et al.. (2019). MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer. Journal of Cancer. 10(12). 2735–2744. 22 indexed citations
10.
Jiang, Kanqiu, Mingjing Shen, Yongbing Chen, & Weihua Xu. (2018). miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway. Oncology Reports. 40(2). 943–951. 18 indexed citations
11.
12.
Jiang, Kanqiu, et al.. (2018). Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation. International Journal of Nanomedicine. Volume 13. 2561–2569. 59 indexed citations
13.
14.
Xu, Weihua, Kanqiu Jiang, Mingjing Shen, Yongbing Chen, & Haoyue Huang. (2015). Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150. Oncology Reports. 35(1). 352–358. 11 indexed citations
15.
Xu, Weihua, et al.. (2015). SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A. Biological Chemistry. 396(8). 929–936. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanya Li Breakdown of academic impact, for papers by Isabelle Moranvillier Breakdown of academic impact, for papers by Vahideh Zarrin Breakdown of academic impact, for papers by Peipei Nie Breakdown of academic impact, for papers by Sara El‐Sahli Breakdown of academic impact, for papers by Malaney R. O’Connell Breakdown of academic impact, for papers by Shengyong Yang Breakdown of academic impact, for papers by Karolina Weiner‐Gorzel Breakdown of academic impact, for papers by Poulami Khan Breakdown of academic impact, for papers by Zike Yang
Rankless by CCL
2026